{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:58:48Z","timestamp":1791032328024,"version":"4.1.0"},"reference-count":18,"publisher":"American Society for Microbiology","issue":"14","license":[{"start":{"date-parts":[[2001,7,15]],"date-time":"2001-07-15T00:00:00Z","timestamp":995155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2001,7,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We measured the longitudinal responses to 95 HLA class I-restricted human immunodeficiency virus (HIV) epitopes and an immunodominant HLA A2-restricted cytomegalovirus (CMV) epitope in eight treatment-naive HIV-infected individuals, using intracellular cytokine staining. Patients were treated with highly active antiretroviral therapy (HAART) for a median of 78 weeks (range, 34 to 121 weeks). Seven of eight patients maintained an undetectable viral load for the duration of therapy. A rapid decline in HIV-specific CD8<jats:sup>+<\/jats:sup>T-cell response was observed at initiation of therapy. After an undetectable viral load was achieved, a slower decrease in HIV-specific CD8<jats:sup>+<\/jats:sup>T-cell response was observed that was well described by first-order kinetics. The median half-life for the rate of decay was 38.8 (20.3 to 68.0) weeks when data were expressed as percentage of peripheral CD8<jats:sup>+<\/jats:sup>T cells. In most cases, data were similar when expressed as the number of responding CD8<jats:sup>+<\/jats:sup>T cells per microliter of blood. In subjects who responded to more than one HIV epitope, rates of decline in response to the different epitopes were similar and varied by a factor of 2.2 or less. Discontinuation of treatment resulted in a rapid increase in HIV-specific CD8<jats:sup>+<\/jats:sup>T cells. Responses to CMV increased 1.6- and 2.8-fold within 16 weeks of initiation of HAART in two of three patients with a measurable CMV response. These data suggest that HAART quickly starts to restore CD8<jats:sup>+<\/jats:sup>T-cell responses to other chronic viral infections and leads to a slow decrease in HIV-specific CD8<jats:sup>+<\/jats:sup>T-cell response in HIV-infected patients. The slow decrease in the rate of CD8<jats:sup>+<\/jats:sup>T-cell response and rapid increase in response to recurrent viral replication suggest that the decrease in CD8<jats:sup>+<\/jats:sup>T-cell response observed represents a normal memory response to withdrawal of antigen.<\/jats:p>","DOI":"10.1128\/jvi.75.14.6508-6516.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:37Z","timestamp":1027764397000},"page":"6508-6516","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":148,"title":["Decay Kinetics of Human Immunodeficiency Virus-Specific CD8<sup>+<\/sup>T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy"],"prefix":"10.1128","volume":"75","author":[{"given":"Joseph P.","family":"Casazza","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Betts","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Picker","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Department of Pathology, University of Oregon Health Science Center, Portland, Oregon2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Koup","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.19.9144-9151.2000"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7108-7116.1999"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.12.1819"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.162.3.1780","article-title":"Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)","volume":"162","author":"Gray C. M.","year":"1999","unstructured":"Gray C. M. Lawrence J. Schapiro J. M. Altman J. D. Winters M. A. Crompton M. Loi M. Kundu S. K. Davis M. M. Merigan T. C. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).J. Immunol. 162 1999 1780 1788","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.8.6721-6728.1999"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.2.169"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/314639"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0898-975"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.10.8179-8184.1999"},{"key":"e_1_3_2_11_2","unstructured":"Korber B. T. Haynes B. F. Koup R. A. Brander C. Moore J. P. Walker B. D. Watkins D. I. HIV molecular immunology database 1999. Theoretical Biology and Biophysics Group T-10 1998 Los Alamos N.Mex"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/314628"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.3.1692"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80470-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.1.797-800.1999"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7371"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/8400"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.9.4127-4138.2000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/35035103"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.14.6508-6516.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.75.14.6508-6516.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:52:54Z","timestamp":1682265174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.75.14.6508-6516.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,15]]},"references-count":18,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2001,7,15]]}},"alternative-id":["10.1128\/JVI.75.14.6508-6516.2001"],"URL":"https:\/\/doi.org\/10.1128\/jvi.75.14.6508-6516.2001","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,15]]},"assertion":[{"value":"2000-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-04-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}